Cancer Nurses Society of Australia, 15th Winter Congress

26 July 2012 - 28 July 2012

Hotel Grand Chancellor, Hobart, Tasmania

Submission Guidelines

Deadline for Submission: Call for Abstracts Deadline EXTENDED to  Monday 19th March 2012 - 5pm EDT


Click here to download the Call for Abstracts Flyer

  • Abstracts should be submitted using the abstract sample as a guide for layout. Click here to download the sample.
  • Papers can only be presented by one presenter 
  • Authors should use Arial Font, Size 12
  • Abstract title should be in BLOCK CAPITALS 
  • Authors names should be on the next line with the surname and initials. 
  • In case of more than one author please underline the name of the presenting author 
  • Do not include degrees or titles  
  • Authors' organizations/institutions should appear on the next line and should include the suburb/city, state and country of the organizations/institutions.  
  • Please use superscript if more than one organization/institution is listed.

Abstract Body Format -
Must be 250 words or less, exclusive of title, author(s) names, and institutional affiliation(s).References will be included in the word count. Please do not use abbreviations unless defined in the abstract. All submissions should be in Microsoft Word format.

Content should include the following sections:


One or two sentences to introduce the topic/area of research and the rationale for the study


Provide a clear statement of the aims of the study.  The hypothesis could be included in this section.  It may also be appropriate to add references to cited literature here.


In this section include information on participants/subjects (e.g. number of participants, demographic information such as age and gender as well as the method of recruitment i.e. random sample or a convenience sample).  Inclusion and exclusion criteria should be included in this section.  Measures and procedures used in the study should be described in this section.  Descriptions of analyses appear in the methods section.


The purpose of this section is to provide a description of the main findings of the study; commenting on potential future results unavailable at the time the abstract was submitted will not be acceptable.  Submitted abstracts must include actual results.  Results should be expressed as means or medians and the spread of the results indicated as ranges, standard deviations or 95% confidence intervals as appropriate.  Probability values must be included, but are not sufficient of themselves without descriptive statistics (means, etc).


In this section you should provide statements of interpretation and implication of findings, as well as comparison with previous literature.  It should not be a simple restatement of the results.


References will be included in the word limit.  Authors are advised to keep references to a minimum and to use an abbreviated referencing system (i.e. First author et al., no title, year of publication, abbreviated journal title, volume, pages).

Word count:

Please ensure that you list your word count at the bottom of the abstract

Presenting Authors

Individuals may serve as a Presenting Author of more than one abstract.

Presenting Authors must:

  • Verify, where necessary for the work reported, that the clinical research represented in the abstract was approved by an appropriate ethics committee or institutional review board and, if appropriate to this research, informed consent was obtained for all subjects;
  • Verify that all co‐authors involved in the research are noted on the abstract and are aware of the submission of the abstract to this congress, are aware of the content of the abstract and support its data;
  • Agree to present the abstract if it is selected for presentation at Winter Congress (this includes being present during the scheduled time of a Poster Session);
  • Agree to include their employing agency/institution;
  • Declare if they or co-authors are employed or sponsored by a commercial interest/body (e.g. a pharmaceutical company).  CNSA reserves the right to review such abstracts for appropriateness and the final decision to include in the congress proceedings is the decision of the CNSA Winter Congress Planning & Development Committee;
  • Use the same contact information and email address for each abstract if submitting more than one abstract.


All abstracts will go through a process of blind review by the abstract review committee within four weeks of the closing date. The CNSA Winter Congress is an opportunity for new researchers to present their findings, and the congress organising committee is eager to assist in the development of research and education for Cancer Nurses.

All presenters must register for a minimum of one day of the Winter Congress by the Early Bird Deadline for registration (14 May 2012) or the presentation will be withdrawn from the program.